280 related articles for article (PubMed ID: 30670494)
1. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
[TBL] [Abstract][Full Text] [Related]
2. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
[TBL] [Abstract][Full Text] [Related]
4. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
Le Vee M; Jouan E; Lecureur V; Fardel O
Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
[TBL] [Abstract][Full Text] [Related]
6. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
7. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
[TBL] [Abstract][Full Text] [Related]
8. Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties.
Reynolds B; Roversi P; Laynes R; Kazi S; Boyd CA; Goberdhan DC
Biochem J; 2009 May; 420(3):363-72. PubMed ID: 19335336
[TBL] [Abstract][Full Text] [Related]
9. CD98 increases renal epithelial cell proliferation by activating MAPKs.
Bulus N; Feral C; Pozzi A; Zent R
PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer.
Ichinoe M; Mikami T; Yanagisawa N; Yoshida T; Hana K; Endou H; Okayasu I; Sengoku N; Ogata H; Saegusa M; Shibuya K; Murakumo Y
J Clin Pathol; 2021 Sep; 74(9):589-595. PubMed ID: 32907912
[TBL] [Abstract][Full Text] [Related]
11. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
12. Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.
Köseer AS; Loureiro LR; Jureczek J; Mitwasi N; González Soto KE; Aepler J; Bartsch T; Feldmann A; Kunz-Schughart LA; Linge A; Krause M; Bachmann M; Arndt C; Dubrovska A
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406454
[TBL] [Abstract][Full Text] [Related]
13. CD98 heavy chain as a prognostic biomarker and target for cancer treatment.
Xia P; Dubrovska A
Front Oncol; 2023; 13():1251100. PubMed ID: 37823053
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation.
Nguyen NNT; Lim YS; Nguyen LP; Tran SC; Luong TTD; Nguyen TTT; Pham HT; Mai HN; Choi JW; Han SS; Hwang SB
Sci Rep; 2018 Oct; 8(1):15486. PubMed ID: 30341327
[TBL] [Abstract][Full Text] [Related]
15. CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression.
Cano-Crespo S; Chillarón J; Junza A; Fernández-Miranda G; García J; Polte C; R de la Ballina L; Ignatova Z; Yanes Ó; Zorzano A; Stephan-Otto Attolini C; Palacín M
Sci Rep; 2019 Oct; 9(1):14065. PubMed ID: 31575908
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
[TBL] [Abstract][Full Text] [Related]
17. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
[TBL] [Abstract][Full Text] [Related]
18. The role of CD98 heavy chain in cancer development.
Park E; Kim H; Yoon S; Jang B
Histol Histopathol; 2024 Apr; ():18749. PubMed ID: 38695393
[TBL] [Abstract][Full Text] [Related]
19. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
[TBL] [Abstract][Full Text] [Related]
20. CD98hc as a marker of radiotherapy-resistant cancer stem cells in head and neck squamous cell carcinoma.
Kawasaki Y; Omori Y; Suzuki S; Yamada T
Arch Med Sci; 2023; 19(6):1859-1868. PubMed ID: 38058706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
